α-Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: A review.


Journal

Nutritional neuroscience
ISSN: 1476-8305
Titre abrégé: Nutr Neurosci
Pays: England
ID NLM: 100892202

Informations de publication

Date de publication:
May 2019
Historique:
pubmed: 1 12 2017
medline: 2 5 2019
entrez: 30 11 2017
Statut: ppublish

Résumé

α-lipoic acid (ALA) is a natural antioxidant which acts as a cofactor of bioenergetic mitochondrial enzymes. Along with its mitochondrial action, ALA and its reduced form have many biological functions resulting in a wide variety of actions such as anti-inflammation and antioxidant protection, scavenging reactive oxygen species, regenerating other antioxidant agents, such as vitamins C and E, and cytosolic glutathione, chelating the transitional metal ions (e.g. iron and copper), and modulating the signal transduction of nuclear factor. By selecting papers from PubMed, Science Direct, EBSCO, and databases, this review discusses the biochemical properties of LA, its mechanism of action, pharmacokinetics, and its possible therapeutic role in central nervous system diseases, such as Alzheimer's disease, Parkinson's disease, Multiple sclerosis, stroke, and spinal cord injury. ALA as an antioxidant and anti-inflammation agent has therapeutical effects on central nervous system diseases, especially multiple sclerosis and PD. ALA can be considered as a potentially useful treatment in central nervous disorders.

Identifiants

pubmed: 29185388
doi: 10.1080/1028415X.2017.1386755
doi:

Substances chimiques

Anti-Inflammatory Agents, Non-Steroidal 0
Antioxidants 0
Chelating Agents 0
Thioctic Acid 73Y7P0K73Y

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

306-316

Auteurs

Fatemeh Seifar (F)

a Neurosciences Research Center, Tabriz University of Medical Sciences , Tabriz , Iran.

Mohammad Khalili (M)

a Neurosciences Research Center, Tabriz University of Medical Sciences , Tabriz , Iran.
e Multiple Sclerosis Research Center , Tehran , Iran.

Habib Khaledyan (H)

b Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Sciences , Tabriz , Iran.

Shirin Amiri Moghadam (S)

c Faculty of Medicine, Department of Community Medicine , Hormozgan University of Medical Sciences , Bandar Abbas , Iran.

Azimeh Izadi (A)

d Faculty of Nutrition and Food Science, Department of Biochemistry and Diet Therapy , Nutrition Research Center, Tabriz University of Medical Sciences , Tabriz , Iran.

Amirreza Azimi (A)

e Multiple Sclerosis Research Center , Tehran , Iran.

Seied Kazem Shakouri (SK)

f Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Sciences , Tabriz , Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH